Walleye Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,400	Closed	-$102K	–	5820
2024 Q3	$102K	Hold	1,400	–	–	﹤0.01%	4389
2024 Q2	$95.9K	Buy	1,400 +1,000	+250%	+$69.4K	﹤0.01%	4735
2024 Q1	$27.7K	Sell	400 -14,000	-97%	-$962K	﹤0.01%	4839
2023 Q4	$1.03M	Hold	14,400	–	–	0.01%	2312
2023 Q3	$750K	Buy	14,400 +100	+0.7%	+$5.83K	0.01%	2481
2023 Q2	$905K	Buy	14,300 +13,100	+1,092%	+$816K	0.02%	1936
2023 Q1	$65K	Sell	1,200 -10,500	-90%	-$508K	﹤0.01%	3111
2022 Q4	$619K	Sell	11,700 -400	-3%	-$20K	0.01%	1317
2022 Q3	$563K	Buy	+12,100	New	+$632K	0.01%	1381
2020 Q1	–	Sell	-62,900	Closed	-$2.16M	–	2039
2019 Q4	$2.16M	Buy	62,900 +39,300	+167%	+$472K	0.47%	178
2019 Q3	$176K	Buy	+23,600	New	+$226K	0.12%	1248
2019 Q2	–	Sell	-3,400	Closed	-$41K	–	2493
2019 Q1	$41K	Buy	+3,400	New	+$43.4K	0.06%	1252